Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
27.28
-0.17 (-0.62%)
Apr 29, 2026, 10:00 AM EDT - Market open
Neurogene Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 426 | 319 | 340 | 249 | - | - |
| Market Cap Growth | 159.40% | -6.03% | 36.64% | - | - | - |
| Enterprise Value | 170 | 64 | 214 | 452 | - | - |
| Last Close Price | 27.45 | 20.60 | 22.86 | 19.38 | - | - |
| PE Ratio | - | - | - | 18.20 | - | - |
| PS Ratio | - | - | 367.11 | - | - | - |
| PB Ratio | 1.61 | 1.21 | 1.09 | 1.34 | - | - |
| P/TBV Ratio | 1.62 | 1.21 | 1.09 | 1.34 | - | - |
| EV/Sales Ratio | - | - | 231.03 | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.04 | 0.08 | 0.05 | 0.06 |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -0.97 | -0.98 | -0.78 | -0.76 |
| Net Debt / EBITDA Ratio | 2.59 | 2.59 | 3.78 | 3.48 | 1.45 | 1.32 |
| Net Debt / FCF Ratio | 3.31 | 3.31 | 4.20 | 3.52 | 1.41 | 1.01 |
| Asset Turnover | - | - | 0.00 | - | - | - |
| Quick Ratio | 16.42 | 16.42 | 20.65 | 8.61 | 12.48 | 6.57 |
| Current Ratio | 16.56 | 16.56 | 20.84 | 8.72 | 12.74 | 6.81 |
| Return on Equity (ROE) | -31.41% | -31.41% | -30.28% | -25.52% | -59.77% | - |
| Return on Assets (ROA) | -20.66% | -20.66% | -18.47% | -20.94% | -33.52% | - |
| Return on Capital Employed (ROCE) | -37.90% | -37.90% | -25.70% | -27.80% | -55.10% | -55.80% |
| Earnings Yield | -21.08% | -28.32% | -22.13% | -14.61% | - | - |
| FCF Yield | -18.28% | -24.56% | -21.03% | -20.82% | - | - |
| Buyback Yield / Dilution | -21.40% | -21.40% | -277.22% | -1080.37% | 90.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.